BHCM
EOLS icon

Brevan Howard Capital Management’s Evolus EOLS Stock Holding History

Brevan Howard Capital Management’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-39,786
Closed -$244K – 1934
2025
Q3 		$244K Buy
+39,786
New +$310K ﹤0.01% 1669

Other funds holding EOLS

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Brevan Howard Capital Management's EOLS Position: Q4 2025 in Review

Brevan Howard Capital Management sold out of Evolus (EOLS) in Q4 2025, closing a stake of 39,786 shares — an estimated $244K sold.

Brevan Howard Capital Management first reported a position in EOLS in Q3 2025 and held it in 1 quarter. The position peaked at $244K in Q3 2025. 169 funds tracked by Wall St. Rank hold EOLS as of Q4 2025.

  • Brevan Howard Capital Management reported no remaining Evolus position as of Q4 2025 after selling out during the quarter.
  • Brevan Howard Capital Management sold 39,786 Evolus shares in Q4 2025, an estimated $244K.
  • Brevan Howard Capital Management first reported a position in Evolus in Q3 2025 and held it in 1 quarter.
  • Brevan Howard Capital Management's Evolus position peaked at $244K in Q3 2025.
  • 169 funds tracked by Wall St. Rank held Evolus as of Q4 2025.

Based on Brevan Howard Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.